Search Results - Oncology

1 Results Sort By:
SR-18465 for Inhibition of MMP-13 in Multiple Myeloma
This patent-pending technology is a SR-18465 compound, which is an osteoclastogenesis matrix metalloproteinase 13 (MMP-13) highly specific inhibitor for the treatment of multiple myeloma. The compound specifically inhibits MMP-13 rather than the entire MMP family of endogenous proteins. SR-18465 directly impacts the viability of several multiple myeloma...
Published: 8/2/2019   |   Inventor(s): Gregg Fields, Conor Lynch
Category(s): Oncology
© 2024. All Rights Reserved. Powered by Inteum